(2016). Demographic and Clinical Characteristics of Patients With Type 2 Diabetes Mellitus Initiating Dipeptidyl Peptidase 4 Inhibitors: A Retrospective Study of UK General Practice. Clin Ther. http://doi.org/10.1016/j.clinthera.2016.07.006.
(2017). Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice. NPJ Prim Care Respir Med. http://doi.org/10.1038/s41533-017-0040-z.
(2018). Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Data. Respir Res. http://doi.org/10.1186/s12931-018-0767-2.
(2019). Real-life prescribing of asthmatic treatments in UK general practice over time using 2014 BTS/SIGN steps. NPJ Prim Care Respir Med. http://doi.org/10.1038/s41533-019-0137-7.
(2019). Temporal variation of renal function in people with type 2 diabetes mellitus: a retrospective UK Clinical Practice Research Datalink cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.13734.
(2019). DPP-4 Inhibitor Dose Selection According to Manufacturer Specifications: A Contemporary Experience From UK General Practice. Clin Ther. http://doi.org/10.1016/j.clinthera.2019.05.010.
(2021). Prescribing in Type 2 Diabetes Patients With and Without Cardiovascular Disease History: a Descriptive Analysis in the UK CPRD. Clin Ther. http://doi.org/10.1016/j.clinthera.2020.12.015.